![Doros Platika](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Doros Platika
Vorstandsvorsitzender bei
Supercentenarian Research Foundation
Profil
Doros Platika is currently the President & Chief Executive Officer at the Supercentenarian Research Foundation and a Director at WorldCare, Inc. He previously served as President & Chief Executive Officer at Curis, Inc., Ontogeny, Inc., Centagenetix, Inc., and Pittsburgh Life Sciences Green House.
He was also a Director at V.I.
Technologies, Inc. and Cohera Medical, Inc. In addition, he held the position of Executive Vice President-Research & Development at Progenitor, Inc. Dr. Platika received his undergraduate degree from The Reed Institute and his doctorate from Stony Brook University.
Aktive Positionen von Doros Platika
| Unternehmen | Position | Beginn |
|---|---|---|
Supercentenarian Research Foundation | Vorstandsvorsitzender | - |
WorldCare, Inc. (Massachusetts)
 WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Doros Platika
| Unternehmen | Position | Ende |
|---|---|---|
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Direktor/Vorstandsmitglied | 11.03.2005 |
| CURIS, INC. | Vorstandsvorsitzender | 01.09.2001 |
Progenitor, Inc.
 Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Technik-/Wissenschafts-/F&E-Leiter | - |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Präsident | - |
Centagenetix, Inc.
 Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | Präsident | - |
Ausbildung von Doros Platika
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
17
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Develops pharmaceutical compounds for nervous system | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Cohera Medical, Inc.
 Cohera Medical, Inc. Medical SpecialtiesHealth Technology Develops surgical adhesives and sealants | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
Centagenetix, Inc.
Centagenetix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics to slow the aging process | Commercial Services |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WorldCare, Inc. (Massachusetts)
WorldCare, Inc. (Massachusetts) Medical/Nursing ServicesHealth Services Develops and commercializes global healthcare services and solutions | Health Services |
Pittsburgh Life Sciences Green House
 Pittsburgh Life Sciences Green House Investment ManagersFinance PLSG invests in companies located in the United States, primarily in Western Pennsylvania. The firm focuses on the life sciences sector. It provides financing for seed, early and growth stage capital requirements. | Finance |
Supercentenarian Research Foundation |
Wählen Sie MarketScreener 
